lobbying_activities: 2774321

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2774321	71457dcb-fe26-4237-b565-339c3ba748c5	Q1	DESIMONE CONSULTING, LLC	400931695	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	2022	first_quarter	PHA	Issues related to patient access and pricing; Issues related to policy changes to Medicare Part D; PDUFA Reauthorization; FY2022 Budget Reconciliation (H.R.5376).	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2022-04-14T15:20:46-04:00